Dietary Intakes and Metabolic Disorders
Metabolic syndrome is defined by a cluster of interrelated cardiovascular risk factors (hyperglycemia, hypertension, dyslipidemia, insulin resistance, and central adiposity), linked to a chronic, systemic, and low-grade inflammation, which severely increases the risk of type II diabetes and cardiova...
Bewaard in:
Andere auteurs: | , |
---|---|
Formaat: | Elektronisch Hoofdstuk |
Taal: | Engels |
Gepubliceerd in: |
Basel
MDPI - Multidisciplinary Digital Publishing Institute
2022
|
Onderwerpen: | |
Online toegang: | DOAB: download the publication DOAB: description of the publication |
Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|
MARC
LEADER | 00000naaaa2200000uu 4500 | ||
---|---|---|---|
001 | doab_20_500_12854_97418 | ||
005 | 20230220 | ||
003 | oapen | ||
006 | m o d | ||
007 | cr|mn|---annan | ||
008 | 20230220s2022 xx |||||o ||| 0|eng d | ||
020 | |a books978-3-0365-4834-0 | ||
020 | |a 9783036548333 | ||
020 | |a 9783036548340 | ||
040 | |a oapen |c oapen | ||
024 | 7 | |a 10.3390/books978-3-0365-4834-0 |c doi | |
041 | 0 | |a eng | |
042 | |a dc | ||
072 | 7 | |a GP |2 bicssc | |
072 | 7 | |a PS |2 bicssc | |
072 | 7 | |a JFCV |2 bicssc | |
100 | 1 | |a Chiva-Blanch, Gemma |4 edt | |
700 | 1 | |a Cofán, Montserrat |4 edt | |
700 | 1 | |a Chiva-Blanch, Gemma |4 oth | |
700 | 1 | |a Cofán, Montserrat |4 oth | |
245 | 1 | 0 | |a Dietary Intakes and Metabolic Disorders |
260 | |a Basel |b MDPI - Multidisciplinary Digital Publishing Institute |c 2022 | ||
300 | |a 1 electronic resource (234 p.) | ||
336 | |a text |b txt |2 rdacontent | ||
337 | |a computer |b c |2 rdamedia | ||
338 | |a online resource |b cr |2 rdacarrier | ||
506 | 0 | |a Open Access |2 star |f Unrestricted online access | |
520 | |a Metabolic syndrome is defined by a cluster of interrelated cardiovascular risk factors (hyperglycemia, hypertension, dyslipidemia, insulin resistance, and central adiposity), linked to a chronic, systemic, and low-grade inflammation, which severely increases the risk of type II diabetes and cardiovascular disease. A growing body of evidence generated in the last decades has shown that not only the energy balance but also the macro-, micro-, and non-nutrient composition of the diet may influence the onset and progression of metabolic syndrome. However, further research is required to increase our understanding about the contribution of diet to metabolic syndrome prevention. | ||
540 | |a Creative Commons |f https://creativecommons.org/licenses/by/4.0/ |2 cc |4 https://creativecommons.org/licenses/by/4.0/ | ||
546 | |a English | ||
650 | 7 | |a Research & information: general |2 bicssc | |
650 | 7 | |a Biology, life sciences |2 bicssc | |
650 | 7 | |a Food & society |2 bicssc | |
653 | |a animal experimentation | ||
653 | |a diet | ||
653 | |a nutrition | ||
653 | |a ingredients | ||
653 | |a lard | ||
653 | |a fibers | ||
653 | |a fructose | ||
653 | |a diet coloring | ||
653 | |a autoclaving | ||
653 | |a irradiation | ||
653 | |a Passiflora setacea | ||
653 | |a bioactive compounds | ||
653 | |a phenolic compounds | ||
653 | |a cardiovascular diseases | ||
653 | |a nutrigenomics | ||
653 | |a gene expression | ||
653 | |a immune system | ||
653 | |a cytokines | ||
653 | |a insulin | ||
653 | |a HDL | ||
653 | |a diabetes mellitus | ||
653 | |a dietary pattern | ||
653 | |a metabotype | ||
653 | |a metabolic phenotype | ||
653 | |a Mediterranean Diet Score | ||
653 | |a Alternate Healthy Eating Index | ||
653 | |a atherosclerosis | ||
653 | |a plaque burden | ||
653 | |a lycopene | ||
653 | |a tomato | ||
653 | |a type 2 diabetes mellitus | ||
653 | |a cis- and trans-isomers | ||
653 | |a nutrients | ||
653 | |a hypertension | ||
653 | |a blood pressure | ||
653 | |a management | ||
653 | |a prevention | ||
653 | |a mitochondria | ||
653 | |a metabolic syndrome | ||
653 | |a mitochondrial dysfunction | ||
653 | |a balanced diet | ||
653 | |a lifestyle | ||
653 | |a Mediterranean diet | ||
653 | |a plant-based diet | ||
653 | |a DASH diet | ||
653 | |a low-carbohydrate diet | ||
653 | |a high-protein diet | ||
653 | |a low-fat diet | ||
653 | |a omega-3 fatty acids | ||
653 | |a metabolism | ||
653 | |a inflammation | ||
653 | |a atherothrombosis | ||
653 | |a clinical trials | ||
653 | |a legacy effect | ||
653 | |a metabolic memory | ||
653 | |a cardiovascular disease | ||
653 | |a diabetes | ||
653 | |a dyslipidaemia | ||
653 | |a abdominal obesity | ||
653 | |a animal protein | ||
653 | |a protein intake | ||
653 | |a Alpha-linolenic acid | ||
653 | |a docosahexaenoic acid | ||
653 | |a rumenic acid | ||
653 | |a punicic acid | ||
653 | |a enriched eggs | ||
653 | |a waist circumference | ||
653 | |a obesity | ||
856 | 4 | 0 | |a www.oapen.org |u https://mdpi.com/books/pdfview/book/5898 |7 0 |z DOAB: download the publication |
856 | 4 | 0 | |a www.oapen.org |u https://directory.doabooks.org/handle/20.500.12854/97418 |7 0 |z DOAB: description of the publication |